Note: Ingredients listed on restricted chemical lists
EC/CAS
209-136-7/556-67-2
Name of the chemical
D4
Concentration
ane; [D4]
EC/CAS
208-764-9/541-02-6
Name of the chemical
D5
Concentration
oxane
EC/CAS
208-762-8/540-97-6
Name of the chemical
D6
Concentration
iloxane
General Information
Version
11.0
Revision date
2022-02-01
Product name
CAF 33 TRANSLUCENT
1.2.1 Relevant identified uses
Used for making joints, sealing and gluing
1.2.2. Uses advised against
None known
supplier name
Elkem Silicones Germany GmbH
Manufacturer Name
Elkem Silicones France SAS
Emergency telephone
+(41)-435082011
Icons in SDS
Company Information
company name
Elkem Silicones France SAS
e-mail address of the competent person responsible for the Safety Data Sheet
fds.sil@elkem.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
Classification according to Regulation (EC) No 1272/2008 as amended Classification of the substance or mixture The product has been classified according to the legislation in force
Signal word
Warning
Hazard statements
H319: Causes serious eye irritation.
Prevention
P280: Wear protective gloves/protective clothing/eye protection/face protection.
Response
P305+P351+P338 IF IN EYES Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 If eye irritation persists Get medical advice/attention UFI E640-F0WF-500T-K7DX
Physical hazards
During curing, the product will release small quantities of irritating vapors Health Hazards: Inhalation: Eye contact: Skin contact No specific symptoms noted Causes serious eye irritation Ingestion No specific symptoms noted
Other Health Effects
No other information noted.
Environmental hazards
No hazard identified as the maximum bioavailable concentration of Octamethylcyclotetrasiloxane (D4) is lower than the classification cut-off value (see Section 12 of this SDS) endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher
Results of PBT and vPvB assessment
This substance/mixture contains components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB). Endocrine Disruption - Health The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Endocrine Disruption - The substance/mixture does not contain components considered to have
Other hazards
No other information noted. Substance(s) formed under the conditions of use Chemical name Concentration* CAS-No. EC No. Classification Acetic acid <3% 64-19-7 200-580-7 Flam. Liq. 3 H226; Skin Corr. 1A H314; * All concentrations are percent by weight unless ingredient is a gas. Gas concentrations are in percent by volume. The full text for all H-statements is displayed in section 16.
2.1 Classification of the substance or mixture
The product has been classified according to the legislation in force. Classification according to Regulation (EC) No 1272/2008 as amended. Health Hazards: Serious eye irritation Category 2 H319: Causes serious eye irritation.
